USA Change Macroaxis User Registration

Home Portfolios Solutions About Us

More ROI Blog

Company Contact UsPress ReleasesTerms Of UseAdvertisingWays To Invest

US Market Open: Feb 9, 16:30 PM 2012

NYSE 8081.25 1.73 Index Moved Down

NASDAQ 2927.23 11.37 Index Moved Up

and more..

sponsered by

Processing
Collecting necessary data for ADMP and ELN...

Asset Comparison and Correlation

View All Portfolios

More Actions
- Select Assests
- Optimize Portfolio
- Suggest Portfolio
- Backtest Watchlist
- Analyze Correlations
- View Transactions
- Check Volatilities
- Import Equities
- Search Equities
- Filter Tops

Adamis Pharmaceuticl and

Elan Corp. plc ADR

Volatility

Matrix

Run Correlation

Diversification

Significant diversification

Overlapping area represents amount of risk that can be diversified away by holding Adamis Pharmaceuticl and Elan Corp. plc ADR in the same portfolio (assuming nothing else is changed)

Optimize

Correlation Coefficient

0.06

Parameters

Time Period	1 Month [change]
Direction	Positive
Strength	Insignificant
Accuracy	88.89%
Values	Daily Returns

Suggest

Adamis Pharmaceuticl

Profile

0.17

Intraday

One Month

^0.00

0.00%

ADMP

OTCBB

Adamis Pharmaceuticl

Day Low	0.16	Open	0.16
Market Cap	15.8M	Volume	491032
Sector	Healthcare	Last Close	0.17
Last Traded	2/9/2012	Year High	Not Applicable
EBITDA	-6.8M	Year Low	Not Applicable
Book Value	-0.022	EPS	-0.076
Day High	0.179	Industry	Drug Delivery
Current EPS	-0.076	This Year EPS	Not Applicable

Elan Corporation plc ADR

Profile

13.17

Intraday

One Month

^(0.27)

2.01%

ELN

NYSE

Elan Corporation plc ADR

P/E	12.34	Day Low	13.00
Open	13.40	P/B Ratio	8.39
Market Cap	7.747B	Volume	4225011
Sector	Healthcare	Last Close	13.44
Short Ratio	2.20	Last Traded	2/9/2012
Year High	14.40	Percent Change	2.01%
EBITDA	196.2M	Year Low	6.10
Absolute Change	0.27	Time	Not Applicable
Book Value	1.602	EPS	1.089
Employees	1,219	Day High	13.61
Target Price	14.25	Current EPS	1.089
This Year EPS	1.14	Next Year EPS	0.10
Current PE	12.34	This Year PE	11.79
Next Year PE	134.40	Dividend	Not Applicable